DiaMedica Therapeutics (DMAC) Enterprise Value (2018 - 2019)
DiaMedica Therapeutics' Enterprise Value history spans 2 years, with the latest figure at -$9.7 million for Q3 2019.
- For Q3 2019, Enterprise Value fell 149.95% year-over-year to -$9.7 million; the TTM value through Sep 2019 reached -$9.7 million, down 149.95%, while the annual FY2018 figure was -$16.8 million, N/A changed from the prior year.
- Enterprise Value reached -$9.7 million in Q3 2019 per DMAC's latest filing, up from -$11.0 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$3.9 million in Q3 2018 to a low of -$16.8 million in Q4 2018.